Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention

Antiplatelet agents are the cornerstone of treatment for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). Clopidogrel, when added to aspirin, has demonstrated considerable success at reducing thrombotic complications of ACS and/or PCI compared to aspir...

Full description

Saved in:
Bibliographic Details
Main Authors: Norgard, Nicholas B, Abu-Fadel, Mazen
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2009
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2773746/
https://ncbi.nlm.nih.gov/pubmed/19898643
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items